Aldesleukin Completed Phase 2 Trials for Stage IV Renal Cell Cancer / Renal Cell Cancer, Recurrent / Stage III Renal Cell Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00032188Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer